175211-73-1

Basic information

• Product Name: Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-(2-oxoethyl)-Methyl ester
• Synonyms: Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-(2-oxoethyl)-Methyl ester;Methyl N-[[(1,1-dimethylethyl)oxy]carbonyl]-N-(2-oxoethyl)glycinate;methyl 2-(tert-butoxycarbonyl)acetate
• CAS NO: 175211-73-1
• Molecular Formula: C₁₀H₁₇NO₅
• Molecular Weight: 231.24568
• Mol File: 175211-73-1.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-(2-oxoethyl)-Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-(2-oxoethyl)-Methyl ester(175211-73-1)
• EPA Substance Registry System: Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-(2-oxoethyl)-Methyl ester(175211-73-1)

Safety Data

• Hazardous Substances Data: 175211-73-1(Hazardous Substances Data)

Upstream product

• 31954-27-5 N-(tert-butoxycarbonyl)glycine methyl ester 

Downstream Products

• 1154868-64-0 4-(3,3-dimethylcyclohexyl)-3-oxopiperazin-1-ium trifluoroacetate 
• 1146412-06-7 methyl N-{2-[(2-cyano-4-fluorophenyl)amino]ethyl}-N-{[(1,1-dimethylethyl)oxy]carbonyl}glycinate 
• 928674-95-7 tert-butyl 4-[4-(piperidin-1-ylmethyl)phenethyl]-3-oxopiperazine-1-carboxylate 

Relevant articles and documents

As the NS4B inhibitor benzofuran analogs (by machine translation)

The present invention discloses a kind of as NS4B benzofuran analogue inhibitors, in particular to the formula (I) below or a pharmaceutically acceptable salt thereof. (by machine translation)

PYRAZOLYLPYRIDINE ANTIVIRAL AGENTS

Provided are compounds of Formula (I) and/or Formula (II) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).

The efficacy and cardiac evaluation of aminomethyl tetrahydronaphthalene ketopiperazines: A novel class of potent MCH-R1 antagonists

The design, synthesis, and biological studies of a novel class of MCH-R1 antagonists based on an aminotetrahydronaphthalene ketopiperazine scaffold is described. Compounds within this class promoted significant body weight reduction in mouse diet induced obesity studies. The potential for hERG blockage activity and QT interval studies in anesthetized dogs are discussed.